1 Memorial Sloan-Kettering Cancer Center and Weill Cornell ...

56. E. Halton, D. Chung, K. Xiao, H. Quintanilla, C. Baldwin, , P. Baird, E. Berman, R.J Brentjens, M. Heaney,J.G. Jurcic, N. Lamanna, T.L. Rosenblat, R.Kaplan, G. Papanicolaou, M.G. Frattini. Micafungin VersusPosaconazole Anti-Fungal Prophylaxis In Adult Patients with Acute Leukemia Undergoing InductionChemotherapy (Abstract# 3556). American Society of Hematology (ASH)54 th Annual Meeting, Dec. 8 -11,2012, Atlanta, Georgia57. M. L Davila, I. Riviere, X. Wang, J. H. Park, J. Stefanski , C. Taylor, Q. He, M. Olszewska, T. Wasielewska, O.Borquez-Ojeda, J. Qu, S. Bartido, J.G. Jurcic, D. Douer, M. G. Frattini, M. Sadelain, R. J Brentjens . MolecularRemission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19-28zCAR-Targeted T Cells (Abstract# 3566). American Society of Hematology (ASH)54 th Annual Meeting, Dec. 8-11, 2012, Atlanta, Georgia58. K. J. Curran, B. Seinstra, Y. Nikhamin, R. Yeh, Y. Usachenko, R. J Brentjens . . Constitutive Expression ofCD40L by CAR-Modified Tumor Targeted T Cells Enhances Anti-Tumor Efficacy Both in Vitro and in Vivo(Abstract# 4120). American Society of Hematology (ASH)54 th Annual Meeting, Dec. 8 -11, 2012, Atlanta,Georgia59. R. Brentjens, M. Davila; J. Park; I. Riviere; X. Wang; M. Frattini, M. Sadelain. Rapid Molecular Remissionand B Cell Aplasia Induced by CD19-Targeted T Cells in Adult Patients with B Cell Acute LymphoblasticLeukemia (B-ALL) (Abstract# 1012). Keystone Symposia 2013 : Cancer Immunology and Immunotherapy,Jan. 27 – Feb. 1 2013, Vancouver, British Columbia, Canada3. Presentations (Optional, not encouraged)Date: _____________________Signature:______________________________________23